Saturna Capital’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-165,072
Closed -$80.4M 167
2024
Q2
$80.4M Buy
165,072
+82,000
+99% +$41.2M 1.07% 32
2024
Q1
$44.9M Buy
83,072
+72
+0.1% +$39.3K 0.62% 45
2023
Q4
$46.1M Hold
83,000
0.72% 45
2023
Q3
$36.3M Hold
83,000
0.64% 51
2023
Q2
$41.7M Buy
83,000
+8,000
+11% +$3.83M 0.72% 50
2023
Q1
$37.5M Buy
+75,000
New +$35.9M 0.73% 49

Other funds holding IDXX

Saturna Capital's IDXX Position: Q3 2024 in Review

Saturna Capital sold out of Idexx Laboratories (IDXX) in Q3 2024, closing a stake of 165,072 shares — an estimated $80.4M sold.

Saturna Capital first reported a position in IDXX in Q1 2023 and held it in 6 quarters. The position peaked at $80.4M in Q2 2024. 1,115 funds tracked by Wall St. Rank hold IDXX as of Q3 2024.

  • Saturna Capital reported no remaining Idexx Laboratories position as of Q3 2024 after selling out during the quarter.
  • Saturna Capital sold 165,072 Idexx Laboratories shares in Q3 2024, an estimated $80.4M.
  • Saturna Capital first reported a position in Idexx Laboratories in Q1 2023 and held it in 6 quarters.
  • Saturna Capital's Idexx Laboratories position peaked at $80.4M in Q2 2024.
  • 1,115 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2024.

Based on Saturna Capital's 13F filing for Q3 2024, filed 5 Nov 2024.